Skip to content
Get alerts
GovInfoNow
Use caution Drug recall · FDA · Published January 30, 2023

Global Pharma Healthcare recalls eye drops with bacterial contamination

Global Pharma Healthcare is recalling lubricant eye drops that were found to have bacterial contamination in unopened bottles. The affected products contain carboxymethylcellulose sodium and were distributed by EzriCare, LLC.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0919-2023DrugGlobal Pharma Healthcare ›
Take action

Contact the company

Recalling firmGlobal Pharma Healthcare Private LimitedA - 9 Sidco Pharmaceutical Complex, Thiruporur · Chennai, India
✎ GovInfoNow plain-language explainer

Global Pharma Healthcare is recalling lubricant eye drops that were found to have bacterial contamination in unopened bottles. This poses a risk of infection if the product is used. Read more at govinfonow.com/recall/33976-global-pharma-healthcare-recalls-eye-drops-with-bacterial-contamination.

Source Summary by GovInfoNow · govinfonow.com/recall/33976-global-pharma-healthcare-recalls-eye-drops-with-bacterial-contamination · Updated August 18, 2026 · FDA enforcement record: FDA #D-0919-2023

Cite this page

“Global Pharma Healthcare recalls eye drops with bacterial contamination.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/33976-global-pharma-healthcare-recalls-eye-drops-with-bacterial-contamination. Based on FDA recall #D-0919-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0919-2023%22&limit=1).

The FDA announced on Jan. 30, 2023, that Global Pharma Healthcare Private Limited is recalling Artificial Tears Lubricant Eye Drops due to non-sterility risks. The agency said the unopened products contained bacterial contamination.

How to tell if you have it

  • Brand: Global Pharma Healthcare
  • Product: Artificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle
  • Distributed by: EzriCare, LLC, Lakewood, NJ
  • NDC: 79503-0101-15
  • Lot codes: PCMI005 (Exp. AUG-2024); PCMJ001, PCMJ002, PCMJ004, PCMJ005, PCMJ006, PCMJ008, PCMJ009, PCMJ010, PCMJ011, PCMJ012, PCMJ013, PCMJ014, PCMJ015 (Exp. MAR-2025)
  • Quantity: 400,008 bottles

The hazard

FDA analysis found unopened products to have bacterial contamination, according to the FDA.

Context

GovInfoNow's records show Global Pharma Healthcare Private Limited has one other recall on record since Feb. 24, 2023. On Feb. 24, 2023, Delsam Pharma recalled Artificial Eye Ointment due to bacterial contamination risk. Other recent recalls of similar products include Thea Pharma Similasan Eye Drops Recall (April 23, 2026), K.C. Pharmaceuticals Recalls Eye Drops Due to Lack of Sterility Assurance (March 3, 2026), and Geri-Care Eye Drops Recalled for Sterility Risk (March 25, 2026).

How to tell if you have this one

Look for the product name 'Artificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops' in 15 ml bottles. The lot numbers PCMI005 through PCMJ015 and expiration dates AUG-2024 or MAR-2025 indicate the affected products.

  • Brand
    Global Pharma Healthcare
  • Category
    Drug
FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Status
    Ongoing
  • Distribution
    Product was distributed to two distributors who further distributed Nationwide in the USA.
Recall numberProduct, codes & lotsClass
D-0919-2023Artificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle, Distributed by. EzriCare, LLC, Lakewood, NJ, NDC 79503-0101-15.; Lot #: PCMI005, Exp. date AUG-2024; PCMJ001, PCMJ002, PCMJ004, PCMJ005, PCMJ006, PCMJ008, PCMJ009, PCMJ010, PCMJ011, PCMJ012, PCMJ013, PCMJ014, PCMJ015, Exp. date MAR-2025Class I
D-0920-2023Artificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle, Distributed by. EzriCare, LLC, Lakewood, NJ, NDC 79503-0101-15.; Lot #: PCMH009, PCMH010, PCMH011, PCMH012, PCMH013, PCMH014, PCMH015, PCMH016, exp. date Nov-2023; PCMI001, PCMI002, PCMI003, PCMI004, PCMI006, PCMI 07, PCMI 008, Exp. date AUG-2024; PCMJ003, PCMJ007, PCMJ016, Exp. date MAR-2025Class II
D-0921-2023Delsam Pharma's ARTIFICIAL TEARS (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1%, 1/2 fl oz (15 ml) bottle, Distributed By: Delsam Pharma Llc, Bronx, New York 10467, NDC 72570 121 15.; Lot #: PCMH001, PCMH002, PCMH005, PCMH007, Exp. date NOV-2023Class I
D-0922-2023Delsam Pharma's ARTIFICIAL TEARS (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1%, 1/2 fl oz (15 ml) bottle, Distributed By: Delsam Pharma Llc, Bronx, New York 10467, NDC 72570 121 15.; Lot #: PCMH003, PCMH004, PCMH006, PCMH008, Exp. date NOV-2023Class II
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot numbers (PCMI005 to PCMJ015) and expiration dates (AUG-2024 or MAR-2025) on the bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was distributed to two distributors who further distributed Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 6 months after the firm started it.

1. Firm started the recall: Jan 30, 202312. FDA classified it Class I: Jul 14, 202323. Published in FDA’s Enforcement Report: Jul 19, 202332023
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Delsam Pharma Artificial Eye Ointment Recall: Bacterial Contamination Risk
Delsam PharmaLEADER Dry Eye Relief Product Recall: Non-Sterile Risk
LEADERThea Pharma Similasan Eye Drops Recall: Sterility Risk from FDA Inspection
Thea PharmaK.C. Pharmaceuticals Recalls Eye Drops Due to Lack of Sterility Assurance
K.C. PharmaceuticalsGeri-Care Eye Drops Recalled for Sterility Risk
Geri-Care

Latest drug recalls

American Health Packaging recalls Metoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health Packaging, Columbus,
American Health Packaging · October 6, 2026Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals,
Teva Pharmaceuticals · September 29, 2026Preferred Pharmaceuticals, Inc. recalls Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A.,
Preferred Pharmaceuticals · September 28, 2026SUN PHARMACEUTICAL INDUSTRIES INC recalls Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro
Northstar Rx · September 25, 2026Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0919-2023 (January 30, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0919-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA